China
China evaluating investigations into pharma firms to take on drug pricing issue
May 9, 2016Business Services, Research and Development, Sales and Marketing China, France, G7, regulation
Lawmakers globally have acknowledged the concerns over unbridled drug costs as regulators stress the need for a more open debate …
Thirty-seven arrested in China vaccine scandal
March 23, 2016Sales and Marketing China, vaccines
Police in China have arrested 37 people in eastern China in relation to illegal vaccine sales conducted by a ring …
Five charged in US for scheme to steal GSK secrets
January 21, 2016Research and Development China, GSK, employee theft, trade secrets
Five people have been charged in the US for a scheme to steal secrets from British drugmaker GlaxoSmithKline and then …
Bayer opens OTC drug plant in China
January 19, 2016Manufacturing and Production Bayer, China, OTC, TCM, Yunnan, over the counter, traditional Chinese medicine
Bayer has opened a new manufacturing plant to produce over-the-counter (OTC) drugs in China, as the German firm looks to …
AstraZeneca to acquire Takeda’s respiratory franchise
December 16, 2015Manufacturing and Production, Research and Development AstraZeneca, China, Takeda, investment, respiratory
AstraZeneca and Takeda have agreed a multi-million pound deal for AZ to acquire the Japanese firm’s core respiratory business, including …
China’s Tianjin invests $300m in Ebola plant
October 20, 2015Manufacturing and Production China, Ebola, Ebola vaccine, manufacturing, production, vaccines
China’s Tianjin CanSino Biotechnology, a developer of affordable vaccines, says that it will invest 2 billion Yuan (£203.3 million) in …
Eleven companies accused in Romanian corruption probe
August 3, 2015Business Services, Medical Communications, Sales and Marketing China, Daily Telegraph, GSK, Roche, Romania, bribery, corruption
GSK and Roche are among eleven pharma firms being investigated for paying bribes to doctors in Romania to prescribe drugs. …
China rejects Gilead’s Sovaldi patent
June 24, 2015Research and Development, Sales and Marketing China, Gilead, hep C, sofosbuvir, sovaldi
Manufacturer of the blockbuster hepatitis C treatment Sovaldi Gilead has seen its application for a patent in China rejected following …
Pfizer expands in China with $95m consumer products plant
June 16, 2015Manufacturing and Production, Sales and Marketing Asia, China, Pfizer, brett wells, production
Pfizer says it has broken ground with a $95 million production facility in Suzhou in China to expand its production …
GSK investigator freed from Chinese prison
June 10, 2015Medical Communications, Sales and Marketing China, GSK, GlaxoSmithKline, brett wells, bribery, scandal
British private investigator Peter Humphrey who worked for GlaxoSmithKline has been released from a Chinese jail following his conviction last …
Another Chinese health official arrested for corruption
May 27, 2015Medical Communications, Sales and Marketing China, GSK, bribery, huang fenping, wang yu
A Chinese health official has been arrested on accusations of bribery as the country continues to crack down on corruption …
Chinese government to lift drug price controls
May 5, 2015Sales and Marketing China, Drug pricing, GSK, IMS, Xarelto, government
The Chinese government has announced that it will remove price caps for most medicines and allow the market to play …
GSK sells off stake in Aspen for $853m
March 13, 2015Sales and Marketing Africa, China, GSK, Novartis, Singapore, aspen, merger, redfern
GlaxoSmithKline has sold off half its stake in South Africa’s Aspen Pharmacare in a move that will net the British …
GSK China scandal leads to staff conflict
March 11, 2015Sales and Marketing China, GSK, GlaxoSmithKline, bribery, chinese, cuts, sacked
Around 135 workers who face being removed from their posts by GlaxoSmithKline due to misconduct centering on bribery scandals in …
Eisai Alzheimer’s drug to see China review
March 4, 2015Sales and Marketing Alzheimer's, Aricept, China, Eisai, donepezil hydrochloride
Alzheimer’s drug Aricept from Eisai has been accepted for review in China to treat patients with the most severe form …
